Treatment of the Localized Pain of Postherpetic Neuralgia

References

• . Dobecki DA, Schocket SM, Wallace MS. Update on pharmacotherapy guidelines for the treatment of neuropathic pain. Curr Pain Headache Rep. 2006;10(3):185–190
   PubMedGoogle Scholar
• . Mäntyselkä P, Kumpusalo E, Ahonen R,. Pain as a reason to visit the doctor: a study in Finnish primary health care. Pain. 2001;89(2–3):175–180
   PubMed Web of Science ®Google Scholar
• . American Pain Society. Classification of Chronic Pain. Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. 2nd ed. Seattle, WA: IASP Press; 1994:1–222
   Google Scholar
• . Carter GT, Galer BS. Advances in the management of neuropathic pain. Phys Med Rehabil Clin N Am. 2001;12(2):447–459
   PubMedGoogle Scholar
• . Attal N, Cruccu G, Haanpaa M,. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006;13(11):1153–1169
   PubMed Web of Science ®Google Scholar
• . Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2004;63(6):959–965
   PubMed Web of Science ®Google Scholar
• . Dworkin RH, O'Connor AB, Backonja M,. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132(3):237–251
   PubMed Web of Science ®Google Scholar
• . Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005;118(3):289–305
   PubMed Web of Science ®Google Scholar
• . Finnerup NB, Otto M, Jensen TS, Sindrup SH. An evidence-based algorithm for the treatment of neuropathic pain. Med Gen Med. 2007;9(2):36
   PubMedGoogle Scholar
• . Moulin DE, Clark AJ, Gilron I,. Pharmacological management of chronic neuropathic pain—consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag. 2007;12(1):13–21
   PubMed Web of Science ®Google Scholar
• . Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9–20
   PubMedGoogle Scholar
• . Bowsher D. Pathophysiology of postherpetic neuralgia: towards a rational treatment. Neurology. 1995;45(12 suppl 8):S56–S57
   Google Scholar
• . Dworkin RH, Schmader KE. Treatment and prevention of postherpetic neuralgia. Clin Infect Dis. 2003;36(7):877–882
   PubMedGoogle Scholar
• . Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports. 2008;57(RR–5):1–30
   PubMedGoogle Scholar
• . Oxman MN, Levin MJ. Vaccination against herpes zoster and postherpetic neuralgia. J Infect Dis. 2008;197( suppl 2):S228–S236
   PubMed Web of Science ®Google Scholar
• . Schmader K, Gnann JW Jr, Watson CP. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis. 2008;197( suppl 2):S207–S215
   PubMed Web of Science ®Google Scholar
• . Lu PJ, Euler GL, Jumaan AO, Harpaz R. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors. Vaccine. 2009;27(6):882–887
   PubMed Web of Science ®Google Scholar
• . Hurley LP, Harpaz R, Daley MF,. National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine. J Infect Dis. 2008;197( suppl 2):S216–S223
   Google Scholar
• . Niv D, Maltsman-Tseikhin A, Lang E. Postherpetic neuralgia: what do we know and where are we heading? Pain Physician. 2004;7(2):239–247
   PubMedGoogle Scholar
• . Davies PS, Galer BS. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia. Drugs. 2004;64(9):937–947
   PubMed Web of Science ®Google Scholar
• . Johnson RW, Whitton TL. Management of herpes zoster (shingles) and postherpetic neuralgia. Expert Opin Pharmacother. 2004;5(3):551–559
   PubMed Web of Science ®Google Scholar
• . Watson CP, Oaklander AL. Postherpetic neuralgia. Pain Prac. 2002;2(4):295–307
   PubMedGoogle Scholar
• . Watson CP, Morshead C, Van der Kooy D, Deck J, Evans RJ. Post-herpetic neuralgia: post-mortem analysis of a case. Pain. 1988;34(2):129–138
   PubMedGoogle Scholar
• . Watson CP, Deck JH, Morshead C, Van der Kooy D, Evans RJ. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain. 1991;44(2):105–117
   PubMed Web of Science ®Google Scholar
• . Chen H, Lamer TJ, Rho RH,. Contemporary management of neuropathic pain for the primary care physician. Mayo Clin Proc. 2004;79(12):1533–1545
   PubMed Web of Science ®Google Scholar
• . Devor M. Sodium channels and mechanisms of neuropathic pain. J Pain. 2006;7(1 suppl 1):S3–S12
   Google Scholar
• . Fields HL, Rowbotham M, Baron R. Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol Dis. 1998;5(4):209–227
   PubMed Web of Science ®Google Scholar
• . Oster G, Harding G, Dukes E, Edelsberg J, Cleary PD. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J Pain. 2005;6(6):356–363
   PubMedGoogle Scholar
• . Backonja MM, Irving G, Argoff C. Rational multidrug therapy in the treatment of neuropathic pain. Curr Pain Headache Rep. 2006;10(1):34–38
   PubMedGoogle Scholar
• . Kost RG, Straus SE. Postherpetic neuralgia—pathogenesis, treatment, and prevention. N Engl J Med. 1996;335(1):32–42
   PubMed Web of Science ®Google Scholar
• . Kishore-Kumar R, Max MB, Schafer SC,. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther. 1990;47(3):305–312
   PubMedGoogle Scholar
• . Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology. 1988;38(9):1427–1432
   PubMed Web of Science ®Google Scholar
• . Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology. 1982;32(6):671–673
   PubMed Web of Science ®Google Scholar
• . Watson CP, Chipman M, Reed K, Evans RJ, Birkett N. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial. Pain. 1992;48(1):29–36
   PubMedGoogle Scholar
• . Sanchez C, Hyttel J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurbiol. 1999;19(4):467–489
   PubMed Web of Science ®Google Scholar
• . Pancrazio JJ, Kamatchi GL, Roscoe AK, Lynch C 3rd. Inhibition of neuronal Na+ channels by antidepressant drugs. J Pharmacol Exp Ther. 1998;284(1):208–214
   PubMed Web of Science ®Google Scholar
• . Nau C, Seaver M, Wang SY, Wang GK. Block of human heart hH1 sodium channels by amitriptyline. J Pharmacol Exp Ther. 2000;292(3):1015–1023
   PubMed Web of Science ®Google Scholar
• . Watson CP, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology. 1998;51(4):1166–1171
   PubMed Web of Science ®Google Scholar
• . Rowbotham MC, Reisner LA, Davies PS, Fields HL. Treatment response in antidepressant-naive postherpetic neuralgia patients: double-blind, randomized trial. J Pain. 2005;6(11):741–746
   PubMed Web of Science ®Google Scholar
• . Khawam EA, Laurencic G, Malone DA Jr. Side effects of antidepressants: an overview. Cleve Clin J Med. 2006;73(4):351–361
   PubMed Web of Science ®Google Scholar
• . Ray WA, Meredith S, Thapa PB, Hall K, Murray KT. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther. 2004;75(3):234–241
   PubMed Web of Science ®Google Scholar
• . Roose SP, Laghrissi-Thode F, Kennedy JS,. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA. 1998;279(4):287–291
   PubMed Web of Science ®Google Scholar
• . Chen Y, Guo JJ, Li H, Wulsin L, Patel NC. Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study. Ann Pharmacother. 2008;42(2):177–184
   PubMed Web of Science ®Google Scholar
• . Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med. 2000;108(1):2–8
   PubMed Web of Science ®Google Scholar
• . Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet. 1998;351(9112):1303–1307
   PubMedGoogle Scholar
• . Jick SS, Li L. Antidepressant drug use and risk of venous thromboembolism. Pharmacotherapy. 2008;28(2):144–150
   PubMed Web of Science ®Google Scholar
• . Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem. 1996;271(10):5768–5776
   PubMed Web of Science ®Google Scholar
• . Pfizer Inc. Lyrica® (pregabalin) [package insert]. New York, NY: Pfizer Inc; 2006
   Google Scholar
• . Rice AS, Maton S. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain. 2001;94(2):215–224
   PubMed Web of Science ®Google Scholar
• . Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998;280(21):1837–1842
   PubMed Web of Science ®Google Scholar
• . Neurontin (gabapentin) capsules, Neurontin (gabapentin) tablets, Neurontin (gabapentin) oral solution [package insert]. New York, NY: Parke-Davis, Pfizer Inc; 2007
   Google Scholar
• . Chandra K, Shafiq N, Pandhi P, Gupta S, Malhotra S. Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial—the GONIP Trial. Int J Clin Pharmacol Ther. 2006;44(8):358–363
   PubMed Web of Science ®Google Scholar
• . Irving G, Jensen M, Cramer M,. Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial. Clin J Pain. 2009;25(3):185–192
   PubMed Web of Science ®Google Scholar
• . Gilron I, Max MB. Combination pharmacotherapy for neuropathic pain: current evidence and future directions. Expert Rev Neurother. 2005;5(6):823–830
   PubMedGoogle Scholar
• . Dworkin RH, Corbin AE, Young JP Jr,. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2003;60(8):1274–1283
   PubMed Web of Science ®Google Scholar
• . Sabatowski R, Gálvez R, Cherry DA,; 1008-045 Study Group.Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain. 2004;109(1–2):26–35
   PubMed Web of Science ®Google Scholar
• . Stacey BR, Barrett JA, Whalen E, Phillips KF, Rowbotham MC. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief. J Pain. 2008;9(11):1006–1017
   PubMed Web of Science ®Google Scholar
• . Drug Enforcement Administration, Department of Justice. Schedules of controlled substances: placement of pregabalin into schedule V Final rule. Fed Regist. 2005;70(144):43633–43635
   PubMedGoogle Scholar
• . US Food and Drug Administration. FDA requires warnings about risk of suicidal thoughts and behaviors for antiepileptic medications. Rockville, MD: US Food and Drug Administration; 2008
   Google Scholar
• . Kochar DK, Garg P, Bumb RA,. Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study. Q J Med. 2005;98(1):29–34
   Google Scholar
• . Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 1998;50(6):1837–1841
   PubMed Web of Science ®Google Scholar
• . Raja SN, Haythornthwaite JA, Pappagallo M,. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2002;59(7):1015–1021
   PubMed Web of Science ®Google Scholar
• . Aronson MD. Nonsteroidal anti-inflammatory drugs, traditional opioids, and tramadol: contrasting therapies for the treatment of chronic pain. Clin Ther. 1997;19(3):420–432
   PubMedGoogle Scholar
• . Bannwarth B. Risk-benefit assessment of opioids in chronic noncancer pain. Drug Saf. 1999;21(4):283–296
   PubMedGoogle Scholar
• . Abel SR. Tramadol: an alternative analgesic to traditional opioids and NSAIDs. J Pharm Care Pain Symptom Control. 1995;3(1):5–29
   Google Scholar
• . Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain. 2003;104(1–2):323–331
   PubMed Web of Science ®Google Scholar
• . Eide PK, Jorum E, Stubhaug A, Bremnes J, Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain. 1994;58(3):347–354
   PubMed Web of Science ®Google Scholar
• . Brill S, Sedgwick PM, Hamann W, Di Vadi PP. Efficacy of intravenous magnesium in neuropathic pain. Br J Anaesth. 2002;89(5):711–714
   PubMed Web of Science ®Google Scholar
• . Baranowski AP, De Courcey J, Bonello E. A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia. J Pain Symptom Manage. 1999;17(6):429–433
   PubMed Web of Science ®Google Scholar
• . Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology. 1991;41(7):1024–1028
   PubMed Web of Science ®Google Scholar
• . Ho KY, Huh BK, White WD, Yeh CC, Miller EJ. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain. Clin J Pain. 2008;24(1):51–55
   PubMed Web of Science ®Google Scholar
• . Rowbotham MC, Davies PS, Fields HL. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol. 1995;37(2):246–253
   PubMed Web of Science ®Google Scholar
• . Galer BS, Jensen MP, Ma T, Davies PS, Rowbotham MC. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain. 2002;18(5):297–301
   PubMed Web of Science ®Google Scholar
• . Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain. 1999;80(3):533–538
   PubMed Web of Science ®Google Scholar
• . Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain. 1996;65(1):39–44
   PubMed Web of Science ®Google Scholar
• . Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial. Clin Drug Invest. 2009;29(4):231–241
   PubMed Web of Science ®Google Scholar
• . Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study. Curr Med Res Opin. 2009;25(7):1663–1676
   PubMed Web of Science ®Google Scholar
• . Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Curr Med Res Opin. 2009;25(7):1677–1687
   PubMed Web of Science ®Google Scholar
• . Binder A, Bruxelle J, Rogers P, Hans G, Bosl I, Baron R. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial. Clin Drug Invest. 2009;29(6):393–408
   PubMed Web of Science ®Google Scholar
• . Hans G, Sabatowski R, Binder A, Boesl I, Rogers P, Baron R. Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study. Curr Med Res Opin. 2009;25(5):1295–1305
   PubMed Web of Science ®Google Scholar
• . Wasner G, Kleinert A, Binder A, Schattschneider J, Baron R. Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin. J Neurol. 2005;252(6):677–686
   PubMed Web of Science ®Google Scholar
• . White WT, Patel N, Drass M, Nalamachu S. Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain. Pain Med. 2003;4(4):321–330
   PubMed Web of Science ®Google Scholar
• . Ball C, Westhorpe R. Local anaesthetics—the introduction of xylocaine into clinical practice. Anaesth Intensive Care. 2004;32(6):733
   PubMedGoogle Scholar
• . Endo Pharmaceuticals Inc. Lidoderm® (lidocaine patch 5%) [package insert]. Chadds Ford, PA: Endo Pharmaceuticals, Inc; 2004
   Google Scholar
• . Argoff CE. New analgesics for neuropathic pain: the lidocaine patch. Clin J Pain. 2000;16( 2 suppl):S62–S66
   PubMedGoogle Scholar
• . Smith KJ, Roberts MS. Sequential medication strategies for postherpetic neuralgia: a cost-effectiveness analysis. J Pain. 2007;8(5):396–404
   PubMedGoogle Scholar
• . Dakin H, Nuijten M, Liedgens H, Nautrup BP. Cost-effectiveness of a lidocaine 5% medicated plaster relative to gabapentin for postherpetic neuralgia in the United Kingdom. Clin Ther. 2007;29(7):1491–1507
   PubMedGoogle Scholar
• . Liedgens H, Hertel N, Gabriel A,. Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspective. Clin Drug Invest. 2008;28(9):583–601
   PubMed Web of Science ®Google Scholar
• . Rains C, Bryson HM. Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging. 1995;7(4):317–328
   PubMed Web of Science ®Google Scholar
• . Bernstein JE, Korman NJ, Bickers DR, Dahl MV, Millikan LE. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol. 1989;21(2 pt 1):265–270
   PubMed Web of Science ®Google Scholar
• . Watson CP, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther. 1993;15(3):510–526
   PubMed Web of Science ®Google Scholar
• . Watson CP. Topical capsaicin as an adjuvant analgesic. J Pain Symptom Manage. 1994;9(7):425–433
   PubMedGoogle Scholar
• . Backonja M, Wallace MS, Blonsky ER,. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol. 2008;7(12):1106–1112
   PubMed Web of Science ®Google Scholar
• . Greenway FL, Frome BM, Engels TM 3rd, McLellan A. Temporary relief of postherpetic neuralgia pain with topical geranium oil. Am J Med. 2003;115(7):586–587
   PubMedGoogle Scholar
• . Abadir AR, Kraynack BJ, Mayda J 2nd, Gintautas J. Postherpetic neuralgia: response to topical clonidine. Proc West Pharmacol Soc. 1996;39:47–48
   PubMedGoogle Scholar
• . De Benedittis G, Lorenzetti A. Topical aspirin/diethyl ether mixture versus indomethacin and diclofenac/diethyl ether mixtures for acute herpetic neuralgia and postherpetic neuralgia: a double-blind crossover placebo-controlled study. Pain. 1996;65(1):45–51
   PubMedGoogle Scholar
• . Tajti J, Szok D, Vecsei L. Topical acetylsalicylic acid versus lidocaine for postherpetic neuralgia: results of a double-blind comparative clinical trial. Neurobiology (Bp). 1999;7(2):103–108
   PubMedGoogle Scholar
• . Bareggi SR, Pirola R, De Benedittis G. Skin and plasma levels of acetylsalicylic acid: a comparison between topical aspirin/diethyl ether mixture and oral aspirin in acute herpes zoster and postherpetic neuralgia. Eur J Clin Pharmacol. 1998;54(3):231–235
   PubMedGoogle Scholar
• . Kikuchi A, Kotani N, Sato T, Takamura K, Sakai I, Matsuki A. Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia. Reg Anesth Pain Med. 1999;24(4):287–293
   PubMed Web of Science ®Google Scholar
• . Acosta EP, Balfour HH Jr. Acyclovir for treatment of postherpetic neuralgia: efficacy and pharmacokinetics. Antimicrob Agents Chemother. 2001;45(10):2771–2774
   PubMedGoogle Scholar
• . Dowd NP, Day F, Timon D, Cunningham AJ, Brown L. Iontophoretic vincristine in the treatment of postherpetic neuralgia: a double-blind, randomized, controlled trial. J Pain Symptom Manag. 1999;17(3):175–180
   PubMedGoogle Scholar
• . Shackelford S, Rauck R, Quessy S, Blum D, Hodge R, Philipson R. A randomized, double-blind, placebo-controlled trial of a selective COX-2 inhibitor, GW406381, in patients with postherpetic neuralgia. J Pain. 2009;10(6):654–660
   PubMed Web of Science ®Google Scholar
• . Bhargava R, Bhargava S, Haldia KN, Bhargava P. Jaipur block in postherpetic neuralgia. Int J Dermatol. 1998;37(6):465–468
   PubMed Web of Science ®Google Scholar
• . Kanai A, Osawa S, Suzuki A, Ishimaru R, Hoka S. Effectiveness of prostaglandin E1 for the treatment of patients with neuropathic pain following herpes zoster. Pain Med. 2007;8(1):36–40
   PubMedGoogle Scholar
• . Hayashida M, Fukuda K, Fukunaga A,. Analgesic effect of intravenous ATP on postherpetic neuralgia in comparison with responses to intravenous ketamine and lidocaine. J Anesth. 2005;19(1):31–35
   PubMedGoogle Scholar
• . Moriyama M, Kitamura A, Ikezaki H,. Systemic ATP infusion improves spontaneous pain and tactile allodynia, but not tactile hypesthesia, in patients with postherpetic neuralgia. J Anesth. 2004;18(3):177–180
   PubMedGoogle Scholar
• . Criscuolo S, Auletta C, Lippi S, Brogi F, Brogi A. Oxcarbazepine monotherapy in postherpetic neuralgia unresponsive to carbamazepine and gabapentin. Acta Neurol Scand. 2005;111(4):229–232
   PubMedGoogle Scholar
• . Rowbotham MC, Manville NS, Ren J. Pilot tolerability and effectiveness study of levetiracetam for postherpetic neuralgia. Neurology. 2003;61(6):866–867
   PubMed Web of Science ®Google Scholar
• . Nishiyama T, Matsukawa T, Yamashita K. Comparison between neurotropin and mepivacaine for stellate ganglion injection. J Anesth. 2006;20(3):240–242
   PubMedGoogle Scholar
• . Kim YH, Lee CJ, Lee SC,. Effect of pulsed radiofrequency for postherpetic neuralgia. Acta Anaesthesiol Scand. 2008;52(8):1140–1143
   PubMedGoogle Scholar
• . Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005;352(13):1324–1334
   PubMed Web of Science ®Google Scholar
• . Graff-Radford SB, Shaw LR, Naliboff BN. Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin J Pain. 2000;16(3):188–192
   PubMedGoogle Scholar
• . Meier T, Wasner G, Faust M,. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain. 2003;106(1–2):151–158
   PubMed Web of Science ®Google Scholar
• . Kotani N, Kushikata T, Hashimoto H,. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med. 2000;343(21):1514–1519
   PubMed Web of Science ®Google Scholar
• . Amjad M, Mashhood AA. The efficacy of local infiltration of triamcinolone acetonide with lignocaine compared with lignocaine alone in the treatment of postherpetic neuralgia. J Coll Phys Surg Pakistan. 2005;15(11):683–685
   PubMedGoogle Scholar
• . Jadad AR, Moore RA, Carroll D,. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12
   PubMedGoogle Scholar
• . Zin CS, Nissen LM, Smith MT, O'Callaghan JP, Moore BJ. An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy. CNS Drugs. 2008;22(5):417–442
   PubMed Web of Science ®Google Scholar
• . Alper BS, Lewis PR. Treatment of postherpetic neuralgia: a systematic review of the literature. J Fam Pract. 2002;51(2):121–128
   PubMed Web of Science ®Google Scholar
• . van Seventer R, Feister HA, Young JP Jr, Stoker M, Versavel M, Rigaudy L. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. Curr Med Res Opin. 2006;22(2):375–384
   PubMed Web of Science ®Google Scholar
• . Wallace MS, Moulin D, Clark AJ,. A Phase II, multicenter, randomized, double-blind, placebo-controlled crossover study of CJC-1008-a long-acting, parenteral opioid analgesic—in the treatment of postherpetic neuralgia. J Opioid Manag. 2006;2(3):167–173
   PubMedGoogle Scholar
• . Nelson KA, Park KM, Robinovtz E, Tsigos C, Max MB. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology. 1997;48(5):1212–1218
   PubMed Web of Science ®Google Scholar
• . Eisenberg E, Kleiser A, Dortort A, Haim T, Yarnitsky D. The NMDA (N-methyl-D-aspartate) receptor antagonist memantine in the treatment of postherpetic neuralgia: a double-blind, placebo-controlled study. Eur J Pain. 1998;2(4):321–327
   PubMed Web of Science ®Google Scholar
• . Sang CN, Booher S, Gilron I, Parada S, Max MB. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology. 2002;96(5):1053–1061
   PubMed Web of Science ®Google Scholar
• . Silver M, Blum D, Grainger J, Hammer AE, Quessy S. Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain. J Pain Symptom Manag. 2007;34(4):446–454
   PubMed Web of Science ®Google Scholar